Video ArticleNear-Infrared Fluorescence with Second-Window Indocyanine Green as an Adjunct to Localize the Pituitary Stalk During Skull Base Surgery
Section snippets
Supplementary Data
References (8)
- et al.
Intraoperative Near-Infrared Optical Contrast Can Localize Brain Metastases
World Neurosurg
(2017) - et al.
Intraoperative Near-Infrared Optical Imaging Can Localize Gadolinium-Enhancing Gliomas during Surgery
Neurosurgery
(2016) - et al.
The second window ICG technique demonstrates a broad plateau period for near infrared fluorescence tumor contrast in glioblastoma
PLoS One
(2017) - et al.
Near-infrared fluorescent image-guided surgery for intracranial meningioma
J Neurosurg
(2018)
Cited by (6)
Indocyanine-green for fluorescence-guided surgery of peripheral nerve sheath tumors – A case report
2021, Interdisciplinary Neurosurgery: Advanced Techniques and Case ManagementCitation Excerpt :Given that’s its targeting effect is mediated by size as opposed to receptor affinity, this delayed – “second window ICG” (SWIG) imaging – demonstrates utility across a spectrum of pathology [4]. To date, the neurosurgical applications of SWIG have been explored in the context of gliomas, intracranial metastases, meningiomas, skull base tumors and the confirmation of stereotactic needle biopsies [4,9–12]. To our knowledge, this report details the first application of SWIG imaging to the surgical management of a peripheral nerve sheath tumor.
5-Aminolevulinic enhanced brain lesions mimic glioblastoma: A case report and literature review
2024, Medicine (United States)Emerging Developments in Skull Base Reconstruction
2023, Skull Base Reconstruction: Management of Cerebrospinal Fluid Leaks and Skull Base DefectsNeuroimaging Precision Tools and Augmented Reality
2022, Contemporary Skull Base Surgery: A Comprehensive Guide to Functional PreservationDeuterated Indocyanine Green (ICG) with Extended Aqueous Storage Shelf-Life: Chemical and Clinical Implications
2021, Chemistry - A European Journal
Supplementary digital content available online.
Conflict of interest statement: J. Y. K. Lee previously owned stock options in VisionSense, the endoscope system used in this video; he no longer has stock options. This work was supported in part by the Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania (J.Y.K.L.). Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000003 (J.K.Y.L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.